- Home
- MRVI vs BOE Comparison
MRVI vs BOE Comparison
Compare MRVI & BOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- BOE
- Stock Information
- Founded
- MRVI 2020
- BOE 2005
- Country
- MRVI United States
- BOE United States
- Employees
- MRVI N/A
- BOE N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- BOE Trusts Except Educational Religious and Charitable
- Sector
- MRVI Health Care
- BOE Finance
- Exchange
- MRVI Nasdaq
- BOE Nasdaq
- Market Cap
- MRVI 809.2M
- BOE 681.7M
- IPO Year
- MRVI 2020
- BOE N/A
- Fundamental
- Price
- MRVI $4.77
- BOE $11.26
- Analyst Decision
- MRVI Buy
- BOE
- Analyst Count
- MRVI 10
- BOE 0
- Target Price
- MRVI $10.28
- BOE N/A
- AVG Volume (30 Days)
- MRVI 1.8M
- BOE 166.1K
- Earning Date
- MRVI 02-25-2025
- BOE 01-01-0001
- Dividend Yield
- MRVI N/A
- BOE 7.30%
- EPS Growth
- MRVI N/A
- BOE N/A
- EPS
- MRVI N/A
- BOE N/A
- Revenue
- MRVI $276,920,000.00
- BOE N/A
- Revenue This Year
- MRVI N/A
- BOE N/A
- Revenue Next Year
- MRVI $2.25
- BOE N/A
- P/E Ratio
- MRVI N/A
- BOE N/A
- Revenue Growth
- MRVI N/A
- BOE N/A
- 52 Week Low
- MRVI $4.28
- BOE $8.80
- 52 Week High
- MRVI $11.56
- BOE $10.48
- Technical
- Relative Strength Index (RSI)
- MRVI 39.85
- BOE 60.85
- Support Level
- MRVI $4.38
- BOE $10.70
- Resistance Level
- MRVI $6.21
- BOE $11.08
- Average True Range (ATR)
- MRVI 0.39
- BOE 0.13
- MACD
- MRVI -0.09
- BOE 0.05
- Stochastic Oscillator
- MRVI 21.31
- BOE 100.00
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About BOE Blackrock Enhanced Global Dividend Trust of Beneficial Interest
Blackrock Enhanced Global Dividend Trust has an investment objective to provide current income and current gains, with a secondary investment objective of long-term capital appreciation. Further, it focuses on investing in a portfolio of equity securities and utilizing an option writing to seek total return performance and enhance distributions.